UBS AM’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-52,356
| Closed | -$410K | – | 2705 |
|
|
2024
Q4 | $410K | Buy |
52,356
+7,765
| +17% | +$60.8K | ﹤0.01% | 2583 |
|
|
2024
Q3 | $586K | Sell |
44,591
-13,708
| -24% | -$180K | ﹤0.01% | 2606 |
|
|
2024
Q2 | $704K | Buy |
+58,299
| New | +$704K | ﹤0.01% | 2528 |
|
|
2023
Q1 | – | Sell |
-15,600
| Closed | -$76.1K | – | 2726 |
|
|
2022
Q4 | $76.1K | Hold |
15,600
| – | – | ﹤0.01% | 2503 |
|
|
2022
Q3 | $225K | Hold |
15,600
| – | – | ﹤0.01% | 2572 |
|
|
2022
Q2 | $236K | Hold |
15,600
| – | – | ﹤0.01% | 2541 |
|
|
2022
Q1 | $185K | Hold |
15,600
| – | – | ﹤0.01% | 2692 |
|
|
2021
Q4 | $253K | Sell |
15,600
-7,819
| -33% | -$127K | ﹤0.01% | 2716 |
|
|
2021
Q3 | $668K | Hold |
23,419
| – | – | ﹤0.01% | 2361 |
|
|
2021
Q2 | $792K | Buy |
23,419
+10,519
| +82% | +$356K | ﹤0.01% | 2335 |
|
|
2021
Q1 | $390K | Sell |
12,900
-3,849
| -23% | -$116K | ﹤0.01% | 2451 |
|
|
2020
Q4 | $829K | Hold |
16,749
| – | – | ﹤0.01% | 2080 |
|
|
2020
Q3 | $643K | Buy |
16,749
+1,000
| +6% | +$38.4K | ﹤0.01% | 2019 |
|
|
2020
Q2 | $680K | Buy |
15,749
+7,749
| +97% | +$335K | ﹤0.01% | 1977 |
|
|
2020
Q1 | $209K | Hold |
8,000
| – | – | ﹤0.01% | 2261 |
|
|
2019
Q4 | $250K | Buy |
+8,000
| New | +$250K | ﹤0.01% | 2417 |
|